文献速递慢性肾脏病遗传性与小管间质肾病

成人与儿童胱氨酸病患者握力研究

Grip Strength in Adults and Children with Cystinosis.
PubMed 文献 · Kidney Int Rep · 2020-11-24

该研究纳入76例成人和儿童胱氨酸病患者,评估握力及其危险因素。患者平均握力z评分为-2.1,低于非胱氨酸病CKD患者;男性、延迟启动半胱胺治疗与握力受损独立相关,成人低体力活动与较低握力z评分相关,而eGFR与握力z评分无显著相关。

要点

  • 胱氨酸病患者握力z评分平均-2.1,低于健康对照和非胱氨酸病CKD患者。
  • 男性及延迟启动半胱胺治疗是握力受损的独立危险因素。
  • 成人低体力活动与较低握力z评分相关,儿童中未见此关联。

核心结论

  • 胱氨酸病患者肌肉力量较健康对照和非胱氨酸病CKD患者受损更明显。
  • 握力受损在男性、延迟启动半胱胺治疗及低体力活动患者中更显著。

研究设计与样本

  • 研究于2017至2019年从胱氨酸病研究网络会议和大型儿童肾脏病诊所招募成人和儿童胱氨酸病患者。
  • 共纳入76例患者,使用握力计评估握力并计算年龄和性别校正的z评分。

主要发现

  • 患者平均握力z评分为-2.1(SD 1.1),低于非胱氨酸病CKD患者。
  • 男性及延迟启动半胱胺治疗与握力受损独立相关。
  • 成人低体力活动与较低握力z评分相关,儿童中无此关联。
  • 三分之一患者报告神经肌肉症状,吞咽问题与较低握力相关。
  • eGFR与握力z评分无显著相关性。

临床怎么用

  • 对胱氨酸病患者应关注握力评估,尤其男性和延迟启动半胱胺治疗者。
  • 成人患者可考虑评估体力活动水平并鼓励适当运动。
  • 吞咽问题可能提示握力下降,需综合评估神经肌肉功能。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Chronic kidney disease (CKD) is associated with impaired muscle strength. Patients with cystinosis have an increased risk for impaired muscle strength because of early development of CKD and cystinosis-induced myopathy. This study assesses muscle strength in patients with cystinosis and investigates risk factors of decreased muscle strength. METHODS: Adult and pediatric patients were recruited from Cystinosis Research Network conferences and a large pediatric nephrology clinic between 2017 and 2019. Patients and caregivers completed questionnaires on demographic characteristics, disease course, daily physical activity, and neuromuscular symptoms. Grip strength was assessed using a dynameter and calculated z-scores for age and sex were assessed for associations with patient characteristics. RESULTS: We included 76 patients with a mean grip strength z-score of -2.1 (SD, 1.1), which was lower than seen in patients with CKD without cystinosis. Male sex and delayed cysteamine initiation were independently associated with impaired grip strength. Among adults, a low level of physical activity was associated with lower grip strength z score, but no association was found in children. A third of the patients reported neuromuscular symptoms, with swallowing issues associated with lower grip strength. There was no significant correlation between eGFR and grip strength z-score. CONCLUSION: Patients with cystinosis have impaired muscle strength compared with healthy control subjects and patients with CKD. This impairment is greater in male patients and in patients with late initiation of cysteamine therapy and is associated with lower physical activity. Further studies investigating the effect of different types of physical activities, optimizing cysteamine therapy, and other interventions are needed.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Iyob-Tessema H, Wang CS, Kennedy S, et al. Grip Strength in Adults and Children with Cystinosis. Kidney Int Rep. 2020. PMID: 33615064. doi:10.1016/j.ekir.2020.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。